follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Monmouth Junction pharma firm adds to leadership team

By

Back to Top Comments Email Print

Latest News

    advertisement

    A Monmouth Junction specialty pharmaceutical company named two new members to its executive team Thursday.

    Tris Pharma, which focuses on technology-based products, hired Sally A. Berry as chief medical officer and Norma Cappetti as vice president of regulatory affairs, it said in a news release.

    Berry is a board certified psychiatrist who has worked with companies such as Pfizer and NextWave Pharmaceuticals during her career. Cappetti has more than 30 years in the pharmaceutical industry, including working with Ono Pharma, Celltech Americas and others.

    "We are very pleased to welcome Sally and Norma to our management team," Ketan Mehta, CEO and president, said in a statement. "Their experience within the medical/clinical and regulatory environments, as well as with the FDA, will be a tremendous asset to Tris as we continue to execute on our pipeline and partnered products."

    ALSO ON NJBIZ:

    Jersey City apartment tower aims to blend arts with luxury living

    Women-owned business logo to showcase on Walmart’s retail packaging

    Despite incentive package, Dietz & Watson facility and jobs will leave N.J.

     

     

     

     

     

    Share This Story On:
    Eric Strauss

    Eric Strauss

    Eric Strauss is the digital content editor for NJBIZ. He has been a reporter and editor for newspapers in New Jersey and Pennsylvania, as well as for a number of websites. You can contact him at erics@njbiz.com or @acerimrat on Twitter.

    advertisement

    Comments


    Be the first to comment.



    Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

    Post Comment
         View Comment Policy

    Advanced search
    Sponsored by
    advertisement
      
      
    advertisement
      
      
    advertisement
    Back to Top